Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | PTGES | O14684 | 5/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.64 |
| ▸ | PPARG | P37231 | 5/20 | 0.64 |
| ▸ | CPA3 | P15088 | 3/20 | 0.64 |
| ▸ | CPA1 | P15085 | 2/20 | 0.58 |
| ▸ | CPB1 | P15086 | 1/20 | 0.58 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | PPARA | Q07869 | 1/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27513375 | 0.98 | FOLH1 (0.68) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL10778624 | 0.95 | FOLH1 (0.68) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL9653477 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL8555594 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL10955140 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL9209348 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL5179711 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL9653480 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL9655121 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG | |
| SCHEMBL10960336 | 0.93 | FOLH1 (0.66) | FOLH1CYP1A2PTGESALOX5PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115216208-A | Nontoxic antirust coating and preparation method thereof | 浙江鱼童新材料股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114316724-A | Aqueous amino corrosion-resistant nano industrial coating and preparation method thereof | 广东美涂士建材股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-112552796-A | Metal flake type bi-component heavy-duty anticorrosive paint and preparation method thereof | 中国南方电网有限责任公司超高压输电公司柳州局 | 2021-03-26 | — | — | CN | claimed |
| US-10843926-B2 | 2-mercaptobenzothiazole modified graphene oxide anti-corrosion coating and method for preparation thereof | XIAMEN UNIVERSITY (CN) | 2020-11-24 | — | — | US | claimed |
| US-20190276318-A1 | 2-MERCAPTOBENZOTHIAZOLE MODIFIED GRAPHENE OXIDE ANTI-CORROSION COATING AND METHOD FOR PREPARATION THEREOF | XIAMEN UNIVERSITY (CN) | 2019-09-12 | — | — | US | claimed |
| CN-117045653-A | Diseases and treatments associated with toxic aldehydes | 奥尔德拉医疗公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-111135171-B | Diseases and treatments associated with toxic aldehydes | 奥尔德拉医疗公司 | 2023-09-08 | — | — | CN | disclosed |
| US-20230151034-A1 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | COCRYSTAL PHARMA, INC. | 2023-05-18 | — | — | US | disclosed |
| CN-115216208-A | Nontoxic antirust coating and preparation method thereof | 浙江鱼童新材料股份有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-114316724-A | Aqueous amino corrosion-resistant nano industrial coating and preparation method thereof | 广东美涂士建材股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-108699558-B | Nucleic acid complexes | 协和麒麟株式会社 | 2021-12-07 | — | — | CN | disclosed |
| CN-112552796-A | Metal flake type bi-component heavy-duty anticorrosive paint and preparation method thereof | 中国南方电网有限责任公司超高压输电公司柳州局 | 2021-03-26 | — | — | CN | disclosed |
| CN-1089269-A | Novel 5-amino-4-hydroxy caproic acid derivative as therapeutical agent | CIBA GEIGY AG (CH) | 1994-07-13 | — | — | CN | disclosed |
| CN-1053607-A | The human immunity that is used for the treatment of AIDS lacks the inhibitor of virus protease | MERCK & CO INC (US) | 1991-08-07 | — | — | CN | disclosed |
| EP-0356223-A2 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1990-02-28 | — | — | EP | disclosed |
| EP-0337714-A2 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1989-10-18 | — | — | EP | disclosed |
| EP-0030588-B1 | PROCESS FOR THE PREPARATION OF P-TERT.-BUTYLBENZALDEHYDE | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-04-25 | — | — | EP | disclosed |
| EP-0010346-A1 | Polyolefins stabilized against light-induced degradation and a light stabilizer composition therefor | AMERICAN CYANAMID COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
| US-4152498-A | CORROSION RESISTANCE, HIGH MELT STABILITY, AGING AND HEAT RESISTANCE | DEMIDOVA VALENTINA M (SU) | 1979-05-01 | — | — | US | disclosed |
| US-4152498-A | CORROSION RESISTANCE, HIGH MELT STABILITY, AGING AND HEAT RESISTANCE | DEMIDOVA VALENTINA M (SU) | 1979-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151034-A1 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | ASNS, GLUL, GNMT | FOLH1 485/4885CYP1A2 4091/4885PTGES 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.